GRB Medical Limited 08896593 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is Sales Agent For Medical Products Digita Accounts Production Advanced 6.30.9574.0 true 08896593 2023-03-01 2024-02-29 08896593 2024-02-29 08896593 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 08896593 bus:Micro-entities 2023-03-01 2024-02-29 08896593 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 08896593 bus:FilletedAccounts 2023-03-01 2024-02-29 08896593 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 08896593 bus:RegisteredOffice 2023-03-01 2024-02-29 08896593 bus:Director1 2023-03-01 2024-02-29 08896593 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 08896593 countries:England 2023-03-01 2024-02-29 08896593 2022-03-01 2023-02-28 08896593 2023-02-28 08896593 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 08896593

GRB Medical Limited

Unaudited Filleted Accounts

for the Year Ended 29 February 2024

 

GRB Medical Limited

(Registration number: 08896593)

Balance Sheet

29 February 2024

2024
£

2023
£

Fixed assets

229,226

117,802

Current assets

68,214

79,022

Prepayments and accrued income

233

-

Creditors: Amounts falling due within one year

(62,559)

(43,546)

Net current assets

5,888

35,476

Total assets less current liabilities

235,114

153,278

Accruals and deferred income

(3,922)

(3,171)

 

231,192

150,107

Capital and reserves

231,192

150,107

 

GRB Medical Limited

(Registration number: 08896593)

Balance Sheet

29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
20 Kirkgate
Sherburn in Elmet
Leeds
North Yorkshire
LS25 6BL

These financial statements were authorised for issue by the director on 25 March 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2023 - 2).

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 25 March 2024.
 

.........................................

G.R. Baker
Director